Sunday, September 30, 2018

Quality FBS-Only 259 USD/500 ml.

First Come; First Serve
We have an inventory of FBS of approximately 2000 bottles.  This inventory includes the lots we've been selling and using internally all year.  These have proven to be of the highest quality.
Here’s a sampling of user feedback: 
  • After a referral from an ex-colleague, we tested a sample from a single batch and found that the product is great for cell cloning & hybridoma work, and generally for all other cell culture. We subsequently ordered several bottles of FBS. The sales person was very friendly and worked with me to make the purchase possible. The order arrived promptly. - Peter Dias, The Biomedical Research Institute of SC
  • We ordered several bottles of Fetal Bovine Serum on 2 occasions and are pleased with its performance in our cultures. The FBS arrived frozen in enough dry ice and was neatly and carefully packed. The FBS was very reasonably priced. Thank you. - Ken Patrene, University of Pittsburgh
Referenced in Publications:
N39 Cell Line Cells grown in Media supplemented with Neuromics' FBS, Courtesy of Deng Guo, University of Iowa.
HEK Cells cultured in Media Supplemented with Neuromics' FBS Courtesy of Kavita Shah, Purdue University

The reason for this great offer is we need to clear inventory so that we can place a volume order of raw FBS stock yet this year and lock in 2019 pricing.  Our goal is to provide the best FBS at the lowest price.  This offer of $259/500ml is valid until the current stock is exhausted.
Like a sample to try?  Contact for a 50 ml sample.  Rose Ludescher-Manager of Customer Satisfaction-

Thursday, September 20, 2018

Human Brain Microvascular Endothelial Cell in Action

Recent Pubs
Our Human Brain Microvascular Endothelial Cells (HBMECs) are known for the performance in drug discovery and tox assays. These 21-CFR compliant cells are used in the "blood side" of our 3-D BBB Models.

  1. Shavali Shaik, Bridget Kennis, Shinji Maegawa, Keri Schadler, Yang Yanwen, Keri Callegari, Rishi R. Lulla, Stewart Goldman, Javad Nazarian, Veena Rajaram, Jason Fangusaro, and Vidya Gopalakrishnan. (2018). REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature. Oncotarget. 2018 Jan 12; 9(4): 5233–5250. doi: 10.18632/oncotarget.23750 
  2. Hu et al. (2016). Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167, 1281–1295.,
GREM-1 is required for tube formation in vitro (A) Q-RT-PCR analysis of GREM-1 gene expression in SU-DIPG-IV cells stably expressing either control shRNA or GREM-1-specific shRNA. Lentiviral constructs expressing two different GREM-1 shRNAs (GREM-1.1 and GREM-1.2) were used to knockdown GREM-1. Efficiency of GREM-1 knockdown was determined by Q-RT-PCR and expression was normalized to 18s RNA. Significance is as shown (**less than.01). (B-C) HUVEC or human brain microvascular endothelial cells (HBMEC) were cultured in endothelial cell medium and or conditioned medium from either control shRNA or shGREM-1.2 transfected SU-DIPG-IV cells. Tube formation in matrigel was measured after 16h and images were obtained. The ability of GREM-1 to rescue loss of tube formation upon REST knockdown was determined by addition of human-recombinant GREM-1 (rGREM-1) to conditioned media-endothelial media mix. Scale bars, 100μm. (C) Quantification of tubes in matrigel shown in Figure B (right panels). Data shown is mean +/- SD, ***p less than .001, n=3. (D) Western blot analysis to assess VEGFR2 levels in SU-DIPG-IV, -VI and –XIII cells, HUVECs and HBMECs was done using anti-VEGFR2 antibodies. Tubulin served as a loading control. (E) Western blot analysis was performed to assess AKT signaling downstream of GREM-1 interaction with its potential receptor VEGFR2 in HUVEC and HBMEC. Anti-pAKT (S473), anti-pAKT (T308), total AKT, and anti-actin were employed.
If these cells fit your assay requirements and need more data/info, do not hesitate to contact me, Pete Shuster, CEO at or cell: 612-801-1007.

Friday, September 14, 2018

Neuromics' BBB Model and Permeability Assays

Crossing the Blood-Brain Barrier
Our BBB Model is being increasingly used by Bio-Pharma for drug permeability studies. Customers include Amgen, Genentech, Boehringer Ingelheim, and Merck.

These assays are key for making sure molecules/compounds of interest will cross the barrier into the brain and at what rate. This data, in part, add clarity on best candidates to move into in-vivo testing.
Human Blood Brain Barrier Model 3D45002 12 well
Human Blood Brain Barrier Model 3D45002 24 well
Human Blood Brain Barrier Model 3D45002 6 wells
I you have interest in using our models, Rose Ludescher, Manager of Customer Satisfaction, can provide information aligned with your assay requiremenst. or 1-866-350-1500.